FRI694 Hypercalcemia And Renal Failure As Initial Presentation Of A Rare Case Of Primary Splenic Large B Cell Lymphoma
Ding N, Majumdar S. FRI694 Hypercalcemia And Renal Failure As Initial Presentation Of A Rare Case Of Primary Splenic Large B Cell Lymphoma. Journal Of The Endocrine Society 2023, 7: bvad114.462. PMCID: PMC10555323, DOI: 10.1210/jendso/bvad114.462.Peer-Reviewed Original ResearchSplenic large B-cell lymphomaLarge B-cell lymphomaB-cell lymphomaDihydroxy vitamin DRenal failureVitamin DPg/mLCell lymphomaPg/Diffuse large B-cell lymphomaR-CHOP therapyPatient underwent splenectomyBence Jones proteinuriaBone marrow biopsyPrimary splenic lymphomaNon-Hodgkin lymphomaPrimary care doctorsAbdominal painElderly patientsInitial presentationUnderwent splenectomyCalcium 1000Further workupMRI abdomenRare etiologyDiabetic Ketoacidosis Associated with Sodium‐Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases
Stamatiades G, D’Silva P, Elahee M, Viana G, Sideri-Gugger A, Majumdar S. Diabetic Ketoacidosis Associated with Sodium‐Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases. International Journal Of Endocrinology 2023, 2023: 6615624. PMID: 37441367, PMCID: PMC10335870, DOI: 10.1155/2023/6615624.Peer-Reviewed Original ResearchCommon presenting symptomAbdominal painEuglycemic DKAPresenting symptomSodium-glucose cotransporter 2 inhibitorsType 2 diabetes mellitusAverage blood glucose concentrationCases of DKAPoor food intakePoor oral intakeCotransporter 2 inhibitorsRetrospective case seriesSGLT2 inhibitor useDiabetic Ketoacidosis AssociatedPotential risk factorsBlood glucose concentrationVariety of drugsAnion gap valuesSGLT2i useDiabetes durationDiabetes mellitusDKA casesInhibitor useOral intakeCase series